Back Home Search

HR+/HER2 neg

    • Protocols
    • UW19046

      OPEN TO ACCRUAL

      WONIX: Pilot Study of FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer

    • UW23049

      OPEN TO ACCRUAL

      ELEVATE: P1b/2 Umbrella study of Elacestrant combinations in metastatic breast cancer

    • UW23076

      OPEN TO ACCRUAL

      Biomarkers to Detect Endocrine Therapy Resistance in Lobular Breast Cancer

    • UW24055

      OPEN TO ACCRUAL

      P3 Study of MK-2870 and Combo w/Pembro, verses Tx of Choice in Pts with HR+/HER2 Adv or Met BC

    • UW25001

      OPEN TO ACCRUAL

      P3 Study of Pf-07220060 + Letrozole Compared to CDK4/6 Inhibitor + Letrozole in Pts w/HR+, HER2- BC